help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 15, 2003
Endocrinology, doi:10.1210/en.2003-0192
A more recent version of this article appeared on August 1, 2003
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
144/8/3382    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, A. J.
Right arrow Articles by Zhu, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, A. J.
Right arrow Articles by Zhu, B. T.

Submitted on February 10, 2003
Accepted on May 5, 2003

Characterization of the Oxidative Metabolites of 17{beta}-Estradiol and Estrone Formed by Fifteen Selectively-Expressed Human Cytochrome P450 Isoforms

Anthony J. Lee1, May Xiaoxin Cai1, Paul E. Thomas1, Allan H. Conney1, and Bao Ting Zhu1*

1 Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208 and Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, College of Pharmacy, Rutgers -- The State University of New Jersey, Piscataway, NJ 08854

* To whom correspondence should be addressed. E-mail: BTZhu{at}cop.sc.edu.

We systematically characterized the NADPH-dependent metabolites of 17{beta}-estradiol and estrone formed by fifteen human cytochrome P450 (CYP) isoforms. CYP1A1 had high activity for estradiol 2-hydroxylation, followed by 15{alpha}-, 6{alpha}-, 4-, and 7{alpha}-hydroxylation. However, when estrone was the as substrate, CYP1A1 formed more 4-hydroxyestrone than 15{alpha}- or 6{alpha}-hydroxyestrone, with 2-hydroxyestrone as the major metabolite. CYP1A2 had the highest activity for the 2-hydroxylation of both estradiol and estrone although it also had activity for their 4-hydroxylation (9-13% of 2-hydroxylation). CYP1B1 mainly catalyzed the formation of catechol estrogens, with 4-hydroxyestrogens predominant. CYP2A6, 2B6, 2C8, 2C9, 2C19, and 2D6 each showed a varying degree of low catalytic activity for estrogen 2-hydroxylation, whereas CYP2C18 and CYP2E1 did not show any detectable estrogen-hydroxylating activity. CYP3A4 had strong activity for the formation of 2-hydroxyestradiol, followed by 4-hydroxyestradiol and an unknown polar metabolite, and small amounts of 16{alpha}- and 16{beta}-hydroxyestrogens were also formed. The ratio of 4- to 2-hydroxylation of estradiol or estrone with CYP3A4 was 0.22 or 0.51, respectively. CYP3A5 had similar catalytic activity for the formation of 2- and 4-hydroxyestrogens. Notably, CYP3A5 had an unusually high ratio of 4- to 2-hydroxylation of estradiol or estrone (0.53 or 1.26, respectively). CYP3A4 and 3A5 also catalyzed the formation of nonpolar estrogen metabolite peaks (less polar than estrone). CYP3A7 had a distinct catalytic activity for the 16{alpha}-hydroxylation of estrone, but not estradiol. CYP4A11 had little catalytic activity for the metabolism of estradiol and estrone. In conclusion, many human CYP isoforms are involved in the oxidative metabolism of estradiol and estrone, with a varying degree of catalytic activity and distinct regioselectivity.


Key words: estradiol • estrone • metabolism • cytochrome P450







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society